Bunge Global SA financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Bunge Global SA files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Revenue	59,152	67,232	59,540	53,108	70,329
Cost of revenue	55,789	63,550	54,695	49,715	66,920
Gross profit	3,363	3,682	4,845	3,393	3,409
Research and development	33	33	35	30	28
Selling, general and administrative	1,234	1,369	1,715	1,776	2,113
Interest expense	243	403	516	471	628
Other non-operating income	509	-9	129	442	289
Pre-tax income	2,565	2,066	3,051	1,524	1,134
Income tax	398	388	714	336	288
Income from continuing operations			2,243	1,137	819
Net income to minority interests	89	68	94	51	27
Net income	2,078	1,610	2,243	1,137	816
EPS, basic	14.50	10.83	15.07	8.09	4.95
EPS, diluted	13.64	10.51	14.87	7.99	4.91
Shares, basic (weighted)	141	149	149	141	165
Shares, diluted (weighted)	152	153	151	142	166
Dividend per share	2.08	2.40	2.61	2.72	2.80

Balance sheet

	FY2021	FY2023	FY2023	FY2024	FY2025
Cash and equivalents	902	1,104	2,602	3,311	1,135
Short-term investments		119	105	484	861
Receivables		2,829	2,592	2,148	3,870
Inventory		8,408	7,105	6,491	13,198
Other current assets		4,381	4,051	4,000	5,789
Total current assets		16,758	16,350	15,958	24,391
Property, plant and equipment		3,617	4,541	5,254	11,678
Lease right-of-use assets		1,024	926	932	1,686
Goodwill		470	489	453	3,141
Intangible assets		360	398	321	309
Long-term investments		163	142	174	136
Other non-current assets		627	615	557	938
Total assets	23,819	24,580	25,372	24,899	44,528
Accounts payable		4,386	3,664	2,777	4,881
Accrued liabilities		755	865	840	1,390
Deferred revenue		601	463	501	814
Short-term debt		846	802	1,544	5,220
Total current liabilities		9,600	7,687	7,435	15,127
Long-term debt		3,259	4,080	4,694	8,831
Lease liabilities		547	566	595	1,097
Other non-current liabilities		849	824	847	1,063
Total liabilities		14,624	13,558	13,954	27,159
Total debt		4,105	4,085	5,363	10,168
Paid-in capital		6,692	5,900	5,325	9,841
Retained earnings		10,222	12,077	12,838	13,152
Treasury stock		-1,320	-1,073	-1,549	-1,007
Other comprehensive income		-6,371	-6,054	-6,702	-6,084
Shareholders' equity		9,224	10,851	9,913	15,904
Minority interests		732	963	1,032	1,465
Total equity	7,825	9,956	11,814	10,945	17,369
Total liabilities and equity		24,580	25,372	24,899	44,528

Cash flow statement

	FY2021	FY2023	FY2023	FY2024	FY2025
Net income	2,167	1,678	2,337	1,188	843
Depreciation and amortization	424	408	451	468	703
Stock-based compensation	61	65	69	65	73
Deferred income tax	-272	-119	-1	-10	-62
Change in receivables	-530	-206	256	169	-469
Change in inventory	-1,301	-269	1,518	96	-700
Change in payables	1,633	67	-939	-538	153
Cash from operations	-2,894	-5,549	3,308	1,900	844
Capital expenditures	-399	-555	-1,122	-1,376	-1,723
Acquisitions			0	0	-4,201
Purchases of investments	-308	-321	-69	-1,285	-2,995
Sales and maturities of investments	171	326	49	887	2,753
Cash from investing	5,113	6,499	-1,009	-1,114	-5,227
Debt issued	1,001	300	1,008	2,045	3,602
Debt repaid	-4	-1,029	-1,176	-753	-2,370
Stock issued	116	92	9	11
Share buybacks	-100	-200	-600	-1,100	-551
Dividends paid	-289	-349	-383	-378	-459
Cash from financing	-1,632	-769	-856	-90	2,229
Net change in cash	524	247	1,471	705	-2,162
Free cash flow	-3,293	-6,104	2,186	524	-879
Interest paid	285	403	507	434	562
Income taxes paid	531	570	655	520	186

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $109.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	4.4%	Gross profit / revenue.
Pre-tax margin	1.1%	Pre-tax income / revenue.
Net margin	0.8%	Net income / revenue.
FCF margin	-1.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	0.7%	Cash from operations / revenue.
Effective tax rate	21.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	4.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.4%	Net income / average total assets.
SG&A / revenue	2.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.2%	Capital expenditures / revenue.
D&A / revenue	1.0%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	32.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y	0.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-28.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-20.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-38.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-22.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-55.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-267.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y	2.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	5.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	60.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	19.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	78.8%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	21.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y	17.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.60x	Current assets / current liabilities.
Quick ratio	0.33x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.09x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.70x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	23.8%	Total debt / total assets.
Liabilities / assets	63.4%	Total liabilities / total assets.
Net debt	$9.71B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$10.15B	Current assets - current liabilities.
Goodwill and intangibles / assets	7.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$12.45B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.69x	Revenue / average total assets.
Fixed asset turnover	6.78x	Revenue / average property, plant and equipment.
Inventory turnover	4.99x	Cost of revenue / average inventory.
Days inventory	73 days	365 x average inventory / cost of revenue.
Receivables turnover	20.3x	Revenue / average receivables.
Days sales outstanding	18 days	365 x average receivables / revenue.
Days payables	29 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	62 days	Days inventory + days sales outstanding - days payables.
FCF conversion	-170.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	297.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.29	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$411.51	Revenue / diluted weighted shares.
FCF per share	-$5.93	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.00	Cash from operations / diluted weighted shares.
Book value per share	$81.97	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$63.61	Tangible book value / shares outstanding.
Cash per share	$8.17	(Cash + short-term investments) / shares outstanding.
Payout ratio	73.8%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$20.94B	Share price x shares outstanding.
Enterprise value	$30.65B	Market cap + total debt - cash - short-term investments.
P/E	30.7x	Market cap / net income. Only when net income is positive.
P/S	0.26x	Market cap / revenue.
P/B	1.31x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.68x	Market cap / tangible book value, when positive.
P/OCF	35.6x	Market cap / cash from operations, when positive.
EV/Sales	0.38x	Enterprise value / revenue.
FCF yield	-5.5%	Free cash flow / market cap.
Earnings yield	3.3%	Net income / market cap (the inverse of P/E).
Dividend yield	2.4%	Dividends paid over the period / market cap.
Shareholder yield	2.4%	(Dividends paid + share buybacks) / market cap.

What was Bunge Global SA's revenue in fiscal 2025?

Bunge Global SA reported revenue of $70.33B for fiscal 2025, 32.4% higher than the year before.

Was Bunge Global SA profitable in fiscal 2025?

Yes. Net income was $816.0M, a net margin of 1.2%.

How much free cash flow did Bunge Global SA generate in fiscal 2025?

Cash from operations of $844.0M minus capital expenditures of $1.72B left free cash flow of -$879.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Bunge Global SA